[Prognostic analysis of 19 newly treated multiple myeloma patients with t(14; 16)]

Y Li1, J R Liu2, J Li2

  • 1Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Myeloma Research Center of Beijing, Beijing 100020, China Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for Hematological Diseases, Beijing 100044, China.